FDA Commissioner Scott Gottlieb hopes to bring the agency’s policies on commercial speech in line with recent industry-friendly legal precedents, the agency head signaled during a Monday (Sept. 11) speech at the 2017 RAPS Regulatory Convergence. The commissioner acknowledged the agency is currently operating in a period of ambiguity and said FDA must have clear guidelines it can feel comfortable enforcing vigorously without fear of running afoul of recent case law. Gottlieb, in his first remarks on the hot-button issue...